279 related articles for article (PubMed ID: 16645489)
1. Prospects for prevention of childhood infections by maternal immunization.
Healy CM; Baker CJ
Curr Opin Infect Dis; 2006 Jun; 19(3):271-6. PubMed ID: 16645489
[TBL] [Abstract][Full Text] [Related]
2. Vaccines in pregnant women and research initiatives.
Healy CM
Clin Obstet Gynecol; 2012 Jun; 55(2):474-86. PubMed ID: 22510631
[TBL] [Abstract][Full Text] [Related]
3. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America.
Pickering LK; Baker CJ; Freed GL; Gall SA; Grogg SE; Poland GA; Rodewald LE; Schaffner W; Stinchfield P; Tan L; Zimmerman RK; Orenstein WA;
Clin Infect Dis; 2009 Sep; 49(6):817-40. PubMed ID: 19659433
[TBL] [Abstract][Full Text] [Related]
4. Maternal immunization.
Glezen WP; Alpers M
Clin Infect Dis; 1999 Feb; 28(2):219-24. PubMed ID: 10064230
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence and placental transportation of maternal antibodies specific for Neisseria meningitidis serogroup C, Haemophilus influenzae type B, diphtheria, tetanus, and pertussis.
de Voer RM; van der Klis FR; Nooitgedagt JE; Versteegh FG; van Huisseling JC; van Rooijen DM; Sanders EA; Berbers GA
Clin Infect Dis; 2009 Jul; 49(1):58-64. PubMed ID: 19480581
[TBL] [Abstract][Full Text] [Related]
6. Can infants be protected by means of maternal vaccination?
Esposito S; Bosis S; Morlacchi L; Baggi E; Sabatini C; Principi N
Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():85-92. PubMed ID: 22862749
[TBL] [Abstract][Full Text] [Related]
7. Maternal immunization to protect the mother and neonate.
Gall SA
Expert Rev Vaccines; 2005 Dec; 4(6):813-8. PubMed ID: 16372877
[TBL] [Abstract][Full Text] [Related]
8. Immunopathology of RSV infection: prospects for developing vaccines without this complication.
van Drunen Littel-van den Hurk S; Mapletoft JW; Arsic N; Kovacs-Nolan J
Rev Med Virol; 2007; 17(1):5-34. PubMed ID: 17004293
[TBL] [Abstract][Full Text] [Related]
9. Prospects for vaccines during pregnancy and in the newborn period.
Fischer GW; Ottolini MG; Mond JJ
Clin Perinatol; 1997 Mar; 24(1):231-49. PubMed ID: 9099512
[TBL] [Abstract][Full Text] [Related]
10. Risks and benefits of immunizing pregnant women: the risk of doing nothing.
Brent RL
Reprod Toxicol; 2006 May; 21(4):383-9. PubMed ID: 16290279
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-infected pregnant women and kinetics of passively acquired antibodies in young infants.
Almeida Vde C; Mussi-Pinhata MM; De Souza CB; Kubo CA; Martinez EZ; Carneiro-Sampaio MM; Duarte G
Vaccine; 2009 Jun; 27(29):3856-61. PubMed ID: 19443091
[TBL] [Abstract][Full Text] [Related]
12. Benefits of early hepatitis B immunization programs for newborns and infants.
Van Herck K; Van Damme P
Pediatr Infect Dis J; 2008 Oct; 27(10):861-9. PubMed ID: 18776823
[TBL] [Abstract][Full Text] [Related]
13. Antipolyribosyl ribitol phosphate response of premature infants to primary and booster vaccination with a combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio virus/Haemophilus influenzae type b vaccine.
Omeñaca F; Garcia-Sicilia J; García-Corbeira P; Boceta R; Torres V
Pediatrics; 2007 Jan; 119(1):e179-85. PubMed ID: 17145903
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
[TBL] [Abstract][Full Text] [Related]
15. Assessments of vaccines for prenatal immunization.
Steinhoff MC
Vaccine; 2013 Aug; 31 Suppl 4():D27-30. PubMed ID: 23973343
[TBL] [Abstract][Full Text] [Related]
16. Paediatric infections: prevention of transmission and disease--implications for adults.
McIntosh ED
Vaccine; 2005 Mar; 23(17-18):2087-9. PubMed ID: 15755576
[TBL] [Abstract][Full Text] [Related]
17. One-year post-primary antibody persistence and booster immune response to a fully liquid five-component acellular pertussis, diphtheria, tetanus, inactivated poliomyelitis, Haemophilus influenzae type b conjugate vaccine.
Lin TY; Wang YH; Huang YC; Chiu CH; Lin PY; Chen CJ; Chavand P; Ortiz E
Int J Infect Dis; 2007 Nov; 11(6):488-95. PubMed ID: 17349809
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.
Pichichero ME; Bernstein H; Blatter MM; Schuerman L; Cheuvart B; Holmes SJ;
J Pediatr; 2007 Jul; 151(1):43-9, 49.e1-2. PubMed ID: 17586189
[TBL] [Abstract][Full Text] [Related]
19. Pertussis vaccination in newborns.
Ulloa-Gutierrez R
Expert Rev Vaccines; 2009 Feb; 8(2):153-7. PubMed ID: 19196195
[TBL] [Abstract][Full Text] [Related]
20. Maternal immunization to benefit the mother, fetus, and infant.
Swamy GK; Garcia-Putnam R
Obstet Gynecol Clin North Am; 2014 Dec; 41(4):521-34. PubMed ID: 25454988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
